2023 | Lymphovascular invasion is an independent prognostic factor in breast cancer irrespective of axillary node metastasis and molecular subtypes
| FRONTIERS IN ONCOLOGY |
2023 | Distinct Prognosis of Minimal Residual Disease According to Breast Cancer Subtype in Patients with Breast or Nodal Pathologic Complete Response After Neoadjuvant Chemotherapy | ANNALS OF SURGICAL ONCOLOGY |
2023 | Oncologic Outcomes in Nipple-sparing Mastectomy with Immediate Reconstruction and Total Mastectomy with Immediate Reconstruction in Women with Breast Cancer: A Machine-Learning Analysis | ANNALS OF SURGICAL ONCOLOGY |
2023 | Efficacy of Limited Dose Modifications for Palbociclib-Related Grade 3 Neutropenia in Hormone Receptor-Positive Metastatic Breast Cancer
| CANCER RESEARCH AND TREATMENT |
2023 | Copy number aberrations in circulating tumor DNA enables prognosis prediction and molecular characterization of breast cancer | JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE |
2023 | Changes in Automated Mammographic Breast Density Can Predict Pathological Response After Neoadjuvant Chemotherapy in Breast Cancer
| KOREAN JOURNAL OF RADIOLOGY |
2023 | On-treatment derived neutrophil-to-lymphocyte ratio and survival with palbociclib and endocrine treatment: analysis of a multicenter retrospective cohort and the PALOMA-2/3 study with immune correlates
| BREAST CANCER RESEARCH |
2022 | Lobular Carcinoma In Situ during Preoperative Biopsy and the Rate of Upgrade
| CANCER RESEARCH AND TREATMENT |
2022 | Ki-67 and breast cancer prognosis: does it matter if Ki-67 level is examined using preoperative biopsy or postoperative specimen? | BREAST CANCER RESEARCH AND TREATMENT |
2021 | The Impact of Post-Mastectomy Radiotherapy on Survival Outcomes in Breast Cancer Patients Who Underwent Neoadjuvant Chemotherapy
| CANCERS |
2021 | Level of Combined Estrogen and Progesterone Receptor Expression Determines the Eligibility for Adjuvant Endocrine Therapy in Breast Cancer Patients
| CANCERS |
2021 | Axillary response according to neoadjuvant single or dual human epidermal growth factor receptor 2 (HER2) blockade in clinically node-positive, HER2-positive breast cancer
| INTERNATIONAL JOURNAL OF CANCER |
2021 | Survival of Breast-Conserving Surgery Plus Radiotherapy versus Total Mastectomy in Early Breast Cancer | ANNALS OF SURGICAL ONCOLOGY |
2021 | Time-Sequencing of the Neutrophil-to-Lymphocyte Ratio to Predict Prognosis of Triple-Negative Breast Cancer
| CANCERS |
2021 | Five-year changes in ovarian function restoration in premenopausal patients with breast cancer taking tamoxifen after chemotherapy: An ASTRRA study report | EUROPEAN JOURNAL OF CANCER |
2021 | Safety and efficacy of everolimus (EVE) plus exemestane (EXE) in postmenopausal women with locally advanced or metastatic breast cancer: final results from EVEREXES | BREAST CANCER RESEARCH AND TREATMENT |
2021 | Clinicopathological Features and Prognosis of Lobular Carcinoma In Situ
| Journal of Breast Disease |
2021 | Genomic landscape of extraordinary responses in metastatic breast cancer
| COMMUNICATIONS BIOLOGY |
2021 | Survival Rates of Breast Cancer Patients Aged 40 to 49 Years according to Detection Modality in Korea: Screening Ultrasound versus Mammography
| KOREAN JOURNAL OF RADIOLOGY |
2020 | Validation of Clinical Treatment Score post-5 years (CTS5) risk stratification in premenopausal breast cancer patients and Ki-67 labelling index
| SCIENTIFIC REPORTS |
2020 | Palbociclib use with grade 3 neutropenia in hormone receptor-positive metastatic breast cancer | BREAST CANCER RESEARCH AND TREATMENT |
2020 | Optimal treatment of pseudoangiomatous stromal hyperplasia of the breast
| ASIAN JOURNAL OF SURGERY |
2020 | Conserving the lymphatics from the arm using fluorescence imaging in patients with breast cancer at high risk of postoperative lymphedema: a pilot study
| GLAND SURGERY |
2020 | Omission of axillary lymph node dissection in patients who underwent total mastectomy with 1 or 2 metastatic lymph nodes
| ANNALS OF SURGICAL TREATMENT AND RESEARCH |
2020 | First Experience in Korea of Stereotactic Partial Breast Irradiation for Low-Risk Early-Stage Breast Cancer
| FRONTIERS IN ONCOLOGY |
2020 | Assessment of the Prognostic Staging System of American Joint Committee on Cancer 8th Edition for Breast Cancer: Comparisons with the Conventional Anatomic Staging System
| JOURNAL OF BREAST CANCER |
2020 | Intermediate HER2 Expression Is Associated With Poor Prognosis in Estrogen Receptor-Positive Breast Cancer Patients Aged 55 Years and Older | BREAST CANCER RESEARCH AND TREATMENT |
2020 | Adding Ovarian Suppression to Tamoxifen for Premenopausal Breast Cancer: A Randomized Phase III Trial | JOURNAL OF CLINICAL ONCOLOGY |
2019 | Adjuvant chemotherapy and survival among patients 70 years of age and younger with node-negative breast cancer and the 21-gene recurrence score of 26-30
| BREAST CANCER RESEARCH |
2019 | An Updated Nomogram for Predicting Invasiveness in Preoperative Ductal Carcinoma In Situ of the Breast
| YONSEI MEDICAL JOURNAL |
2019 | Is the frozen section examination for sentinel lymph node necessary in early breast cancer patients?
| Annals of Surgical Treatment and Research |
2019 | Aromatase inhibitor use is a risk factor of carotid plaque presence in endocrine-responsive breast cancer patients
| KOREAN JOURNAL OF INTERNAL MEDICINE |
2019 | Prevalence of breast cancer-related risk factors in underweight premenopausal women: the Korea National Health and Nutrition Examination Survey IV-VI | BREAST CANCER RESEARCH AND TREATMENT |
2018 | Impact of Micrometastatic Axillary Nodes on Survival of Breast Cancer Patients with Tumors ≤2 cm | WORLD JOURNAL OF SURGERY |
2018 | Assessment of Quality of Life and Safety in Postmenopausal Breast Cancer Patients Receiving Letrozole as an Early Adjuvant Treatment.
| JOURNAL OF BREAST CANCER |
2018 | Feasibility of Charcoal Tattooing of Cytology-Proven Metastatic Axillary Lymph Node at Diagnosis and Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy in Breast Cancer Patients
| CANCER RESEARCH AND TREATMENT |
2018 | Association between Changes in Serum 25-Hydroxyvitamin D Levels and Survival in Patients with Breast Cancer Receiving Neoadjuvant Chemotherapy
| JOURNAL OF BREAST CANCER |
2018 | Can Biannual Ultrasound Surveillance Detect Smaller Second Cancers or Detect Cancers Earlier in Patients with Breast Cancer History? | ULTRASOUND IN MEDICINE AND BIOLOGY |
2017 | Basic Facts of Breast Cancer in Korea in 2014: The 10-Year Overall Survival Progress
| JOURNAL OF BREAST CANCER |
2017 | Prognostic value of ABO blood types in young patients with breast cancer; a nationwide study in Korean Breast Cancer Society | MEDICAL ONCOLOGY |
2017 | Comparison of characteristics in patients with both thyroid and breast cancer: Based on order of incidence
| Korean Journal of Clinical Oncology (대한임상종양학회지) |
2017 | Factors predictive of occult nipple-areolar complex involvement in patients with carcinoma in situ of the breast | JOURNAL OF SURGICAL ONCOLOGY |
2017 | Lack of both androgen receptor and forkhead box A1 (FOXA1) expression is a poor prognostic factor in estrogen receptor-positive breast cancer
| ONCOTARGET |
2017 | Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy
| NEW ENGLAND JOURNAL OF MEDICINE |
2016 | Expression of T-Lymphocyte Markers in Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer
| JOURNAL OF BREAST CANCER |
2016 | Breast ultrasonography for detection of metachronous ipsilateral breast tumor recurrence | ACTA RADIOLOGICA |
2016 | Risk Factors Associated with Discordant Ki-67 Levels between Preoperative Biopsy and Postoperative Surgical Specimens in Breast Cancers
| PLOS ONE |
2016 | Magnetic Resonance Imaging after Completion of Neoadjuvant Chemotherapy Can Accurately Discriminate between No Residual Carcinoma and Residual Ductal Carcinoma In Situ in Patients with Triple-Negative Breast Cancer
| PLOS ONE |
2015 | Negative Impact of Aromatase Inhibitors on Proximal Femoral Bone Mass and Geometry in Postmenopausal Women with Breast Cancer | CALCIFIED TISSUE INTERNATIONAL |
2015 | Characteristics and Survival of Breast Cancer Patients with Multiple Synchronous or Metachronous Primary Cancers
| YONSEI MEDICAL JOURNAL |